Infants and toddlers diagnosed with unilateral cerebral palsy, a neurological disorder impacting muscle control on one side of the body, have historically faced significant challenges in developing arm and hand function. However, a groundbreaking multisite clinical trial led by researchers at Virginia Tech’s Fralin Biomedical Research Institute at VTC offers compelling new evidence that early, intensive therapies can markedly enhance motor outcomes in this vulnerable population. This landmark study sheds light on the profound neuroplasticity of the infant brain and the therapeutic potential of targeted interventions within a critical early developmental window.
The trial, known as the Baby CHAMP (Children with Hemiparesis Arm-and-Hand Movement Project) study, directly compared three distinct, therapist-administered treatment modalities designed to improve upper extremity function in children aged 6 to 24 months with unilateral cerebral palsy. These interventions included two variations of constraint-induced movement therapy (CIMT), where the unaffected limb is restrained to encourage use of the affected arm, and bimanual therapy (BIM), which encourages coordinated bilateral hand use without limb restriction. By juxtaposing these methods within rigorously standardized clinical protocols, the research team sought to clarify the relative efficacy of these approaches during early development.
Key findings from the Baby CHAMP trial demonstrate that all three intervention strategies yield comparable improvements in fine motor skills and functional use of both the impaired and non-impaired arms. Participants received a robust dosage of therapy, consisting of three hours daily for five consecutive days over a span of four weeks, resulting in an intensive 60-hour regimen complemented by guided home exercises. This high-dose, play-based therapy capitalizes on the extraordinary synaptic malleability and experiential responsiveness of the infant nervous system, which undergoes rapid growth and reorganization in the first two years of life.
Neurodevelopmentally, the first 24 months represent a profound period of heightened neuroplasticity, wherein motor circuits remain exquisitely sensitive to both environmental stimuli and therapeutic inputs. By initiating interventions during this window, the Baby CHAMP study leverages intrinsic brain adaptability to facilitate remodeling of sensorimotor pathways, restore interhemispheric connectivity, and enhance functional neural representations of the affected limb. The comparable efficacy observed across treatment arms raises important questions about the mechanistic underpinnings of motor skill acquisition in this early stage, suggesting that intensive, repetitive practice—whether constrained or bilateral—may be sufficient to catalyze meaningful improvements.
Historically, constraint-induced movement therapy has been favored for its hypothesized ability to overcome “learned non-use” of the affected limb by forcing its engagement through physical restraint of the contralateral arm. Conversely, bimanual therapy aims to reinforce integrated, coordinated use of both limbs, reflecting functional demands of everyday tasks. The Baby CHAMP data challenges assumptions that constraining the stronger arm is categorically superior, revealing that the splint-supported and bimanual interventions achieve similar functional gains. Interestingly, the study also alleviates concerns about potential developmental delays in the less-affected arm due to restraint, with evidence showing no impairments—and in some cases, modest improvements—in the fine motor skills of the uninvolved limb at six-month follow-ups, particularly in those undergoing full-time casting.
The trial enrolled 58 participants, with 53 completing the intervention and outcome evaluations immediately post-treatment, and 41 returning for six-month longitudinal assessments. Outcomes were assessed via standardized developmental motor scales administered by blinded evaluators to minimize bias. Beyond immediate therapeutic gains, children demonstrated sustained—or even enhanced—functional improvements at follow-up, indicating ongoing neural reorganization and skill consolidation after formal therapy concluded. This delayed trajectory underscores the importance of continued monitoring and potential booster interventions across early childhood.
From a practical standpoint, the study’s findings expand the therapeutic toolkit available to clinicians and families, providing evidence-based flexibility in selecting intervention strategies tailored to individual child needs, family preferences, and contextual feasibility. The fact that multiple intensive therapy formats yield similar benefits empowers caregivers and healthcare providers to prioritize early, consistent engagement in rehabilitation without undue concern over modality choice. Moreover, the report of transient distress in children wearing casts or splints—and minor, non-threatening skin irritation in a small minority—attests to the overall feasibility and tolerability of these intensive regimens.
The Baby CHAMP trial was conducted through a collaborative network of institutions, including Virginia Tech, The Ohio State University, and Nationwide Children’s Hospital, ensuring broad representation and rigorous fidelity in therapeutic delivery. Therapists underwent centralized training to implement structured, play-based motor learning paradigms emphasizing repetition, positive reinforcement, and incrementally challenging activities. This methodological consistency strengthens the validity and generalizability of the findings, marking a significant advance in evidence-based early intervention research for unilateral cerebral palsy.
Looking forward, the researchers underscore the need for extended longitudinal studies to elucidate how these early therapeutic gains translate into diverse domains of child development, such as cognitive, social-emotional, and adaptive functioning. Additionally, integrating neuroimaging and neurophysiological biomarkers could illuminate the neural correlates of observed behavioral improvements and inform the refinement of individualized treatment algorithms. The promising outcomes evidenced by the Baby CHAMP study offer a hopeful paradigm shift, underscoring the transformative impact of early, intensive intervention in harnessing the brain’s plasticity to reshape developmental trajectories for children with unilateral cerebral palsy.
Stephanie DeLuca, associate professor and director of the Fralin Biomedical Research Institute’s Neuromotor Research Clinic, emphasizes the significance of this work: “The remarkable plasticity of the brain in the first two years presents a critical window to influence motor system development positively. Our findings confirm that diverse therapeutic approaches, when delivered intensively and early, can yield robust improvements, fundamentally changing the outlook for affected children.” Co-investigator Sharon Landesman Ramey concurs, highlighting the practical implications: “Families now have actionable, evidence-based options to guide care during one of the most vital periods for neurodevelopment, reinforcing the imperative for early identification and intervention.”
This multisite clinical trial, funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, represents a milestone in pediatric neurorehabilitation research, bridging gaps in clinical evidence and offering a scientifically grounded roadmap for improving the lives of children affected by unilateral cerebral palsy worldwide.
Subject of Research: People
Article Title: Comparative Efficacy RCT of 3 Intensive Infant/Toddler Therapies for Unilateral Cerebral Palsy
News Publication Date: 20-Feb-2026
Web References:
- Study published in Pediatrics Open Science: https://publications.aap.org/pediatricsopenscience/article/2/1/1/206520/Comparative-Efficacy-RCT-of-3-Intensive-Infant?autologincheck=redirected
- DOI link: http://dx.doi.org/10.1542/pedsos.2025-000676
Image Credits: Jennifer Murray
Keywords: Pediatrics, Cerebral palsy, Caregivers, Movement disorders, Developmental neuroscience
